Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
![](/xmlui/themes/Mirage2//images/mime.png)
Access
info:eu-repo/semantics/closedAccessDate
2014Author
Bilici, AhmetSelçukbiricik, Fatih
Demir, Nazan
Öven Ustaalioğlu, Bala Başak
Dikillitaş, Mustafa
Yıldız, Özcan
Metadata
Show full item recordCitation
Bilici, A., Selçukbiricik, F., Demir, N., Öven Ustaalioğlu, B. B., Dikillitaş, M. ve Yıldız, Ö. (2014). Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL: American Society of Clinical Oncology.Abstract
…
WoS Q Kategorisi
Q1Source
50th Annual Meeting of the American-Society-of-Clinical-OncologyVolume
32Issue
15Collections
- Bildiri Koleksiyonu [516]
- WoS İndeksli Yayınlar Koleksiyonu [6677]